Buvidal 32 mg Prolonged-release solution for injection

Licence status
Authorised: 20/11/2018
Active substances
Buprenorphine
Dosage Form
Prolonged-release solution for injection
Licence number
EU/1/18/1336/004
Licence holder
Camurus AB

Product documents

Licence information

ATC code
N07BC Drugs used in opioid dependence, N07BC01 buprenorphine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to special and restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2). This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/11/2018